🔎 Trials Near Me

Pradžia › Psichikos sutrikimai › New Jersey

Psichikos sutrikimai klinikiniai tyrimai New Jersey

7 tyrimai dėl Psichikos sutrikimai ieško dalyvių vietose New Jersey.

Miestai New Jersey

Oficialus tyrimo tekstas (anglų kalba)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, West Long Branch
Renkami dalyviai2 fazė
Amžius nuo 55 iki 90 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06887192

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Marlton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • CenExel AMRI, Toms River
Renkami dalyviai1 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-08-24 · NCT06297590

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Clinilabs, LLC, Eatontown
  • Bio Behavioral Health, Toms River
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-11 · NCT06524830

A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder

  • Vistagen Clinical Site, Toms River
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-02-05 · NCT06809179

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

  • Rutgers University Primary Care Clinics, New Brunswick
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-03 · NCT06387290

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Toms River
Renkami dalyviai2 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-02-02 · NCT07105709

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.